subject: PUBCHEM.COMPOUND:133604

subject_name: Collagen

object_name: Shoulder pain


subject: PUBCHEM.COMPOUND:133604

object_name: Tendinitis of shoulder region

tested_intervention: unsure


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: CHEBI:3815


subject: CHEBI:3815


subject: UMLS:C0009325

subject_name: collagen


subject: UMLS:C0009325


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: cerebral toxoplasmosis

tested_intervention: yes


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Blood Pressure Finding


subject: CHEBI:4466

object_name: Systemic arterial pressure


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:93775

subject_name: Amethopterin

object_name: fasciitis


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UMLS:C0939260

subject_name: aviane

object_name: body weight


subject: UMLS:C1170534

subject_name: Portia brand of ethinyl estradiol/levonorgestrel


subject: CHEBI:63577

subject_name: Lamivudine

object_name: Small cell lung cancer extensive stage


subject: UNII:L585GDK9YN

subject_name: BIFIDOBACTERIUM BREVE BR03

object_name: Infantile Colic


subject: UNII:9N4P294L2R

subject_name: BIFIDOBACTERIUM BREVE B632


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: metastatic colorectal cancer


subject: GTOPDB:9758

object_name: Secondary malignant neoplasm of lung


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:6121

subject_name: Ketamine

object_name: Fused cervical vertebrae


subject: CHEBI:39465

subject_name: timolol

object_name: portal hypertension


subject: CHEBI:39465

object_name: Portal Hypertension, CTCAE


subject: CHEBI:39465

object_name: liver cirrhosis


subject: CHEBI:39465

object_name: esophageal varices


subject: PUBCHEM.COMPOUND:2269

object_name: gonorrhea


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: MESH:D010919

subject_name: Placebos

object_name: Hyperhidrosis, CTCAE


subject: MESH:D010919

object_name: Hyperhidrosis


subject: CHEBI:42797

subject_name: Gabapentin

object_name: fibromyalgia


subject: CHEBI:55379

subject_name: camphorsulfonic acid

object_name: atopic eczema


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Disorder of fetus or newborn


subject: CHEBI:6888

object_name: congenital heart disease


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: high-risk pregnancy


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Iron deficiency without anemia


subject: CHEBI:192614

object_name: Post-Traumatic Headache


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660


subject: UNII:80X7B1F6NW


subject: CHEBI:9139


subject: UNII:G1G66XE93W

object_name: Gastroesophageal junction cancer


subject: CHEBI:24866

subject_name: salt

object_name: hypertension


subject: CHEBI:24866

object_name: Hypertension, CTCAE


subject: CHEBI:167204

subject_name: Mosapride

object_name: type 2 diabetes mellitus


subject: CHEBI:8382

subject_name: Prednisone

object_name: lipoid nephrosis


subject: UNII:URS0374MIV

subject_name: RIPERTAMAB


subject: UMLS:C4053591

subject_name: Ripertamab


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN

object_name: diabetic foot


subject: UNII:X00B0D5O0E

object_name: diabetes mellitus


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:8232


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:9421


subject: UNII:5Q7R99CKV2

subject_name: Fisogatinib

object_name: liver carcinoma


subject: UMLS:C4086294


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Gambling


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C1739076

object_name: Carcinoma breast stage IV


subject: UMLS:C3541937

subject_name: Azadirachta indica whole extract

object_name: Gingival bleeding


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IB Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:31355

object_name: Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IIA Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:31355

object_name: Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IIB Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:31355

object_name: Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IIIA Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:31355

object_name: Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IIIC Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:31355

object_name: Stage IIIB Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:31355

object_name: Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: PUBCHEM.COMPOUND:56776542

subject_name: Andecaliximab

object_name: rheumatoid arthritis


subject: UNII:571045EIM4

subject_name: andecaliximab


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: mantle cell lymphoma


subject: UNII:8M7YSN2KII

object_name: Childhood Diffuse Large Cell Lymphoma


subject: UNII:8M7YSN2KII

object_name: diffuse large B-cell lymphoma


subject: UNII:8M7YSN2KII

object_name: Adult Diffuse Large Cell Lymphoma


subject: UNII:8M7YSN2KII

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UMLS:C4763649

subject_name: CDK4/6 Inhibitor BPI-16350

object_name: Childhood Breast Carcinoma


subject: UMLS:C4763649

object_name: breast carcinoma


subject: UMLS:C4763649

object_name: breast cancer


subject: CHEBI:74854

subject_name: Thr-Asp

object_name: pneumococcal infection


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: UMLS:C0305060

subject_name: Tetanus and diphtheria toxoid adsorbed for adult use


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: stage IV esophageal cancer


subject: UMLS:C5834084

object_name: cardiovascular disorder


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: secondary hypertension


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor


subject: CHEBI:35457

object_name: essential hypertension


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: CHEBI:7421

subject_name: NAC

object_name: ST-elevation myocardial infarction


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: UMLS:C1170041

subject_name: Alphagan P

object_name: ocular hypertension


subject: UMLS:C1170041

object_name: Ocular hypertension


subject: UMLS:C1170041

object_name: open-angle glaucoma


subject: UMLS:C3827106

object_name: thyroid tumor


subject: UMLS:C3827106

object_name: thyroid gland carcinoma


subject: UMLS:C3827106

object_name: thyroid cancer


subject: CHEBI:66910

subject_name: Axitinib

object_name: malignant pleural mesothelioma


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:49603

object_name: Prostate cancer stage I


subject: CHEBI:49603

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:49603

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:49603

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:49603

object_name: Stage IIA Prostate Cancer AJCC v8


subject: CHEBI:49603

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:49603

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:49603

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:49603

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:49603

object_name: Carcinoma of the prostate stage III


subject: CHEBI:49603

object_name: Stage III Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:23431961

subject_name: Sodium citrate

object_name: arthritis


subject: PUBCHEM.COMPOUND:23431961

object_name: Arthritis, CTCAE


subject: CHEBI:30769

subject_name: Citric acid


subject: CHEBI:30769


subject: UMLS:C4725760

subject_name: Personalized Synthetic Long Peptide Vaccine

object_name: triple-negative breast carcinoma


subject: UMLS:C4725760

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:L500PR95QA

object_name: obesity


subject: UNII:L500PR95QA

object_name: Obesity, CTCAE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: UMLS:C2077029

subject_name: inhaled budesonide

object_name: respiratory failure


subject: UMLS:C2077029

object_name: acute respiratory failure


subject: UMLS:C2077029

object_name: Hypoxemia


subject: UMLS:C2077029

object_name: Blood oxygen concentration below reference range (finding)


subject: UMLS:C2077029

object_name: pneumonia


subject: UMLS:C2077029

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C2077029

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:5147


subject: CHEBI:5147


subject: CHEBI:5147


subject: CHEBI:5147


subject: CHEBI:5147


subject: CHEBI:5147


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:408174


subject: CHEBI:408174


subject: CHEBI:408174


subject: CHEBI:408174


subject: CHEBI:408174


subject: CHEBI:408174


subject: UNII:Q91187K011

subject_name: Tetraferric tricitrate decahydrate

object_name: Anemia in chronic kidney disease


subject: CHEBI:144421

subject_name: ferric citrate


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: bone marrow neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UNII:3A189DH42V

subject_name: Alemtuzumab


subject: UNII:3A189DH42V

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: UNII:3A189DH42V

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UNII:3A189DH42V

object_name: aplastic anemia


subject: UNII:3A189DH42V

object_name: idiopathic aplastic anemia


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: myeloproliferative neoplasm


subject: GTOPDB:4942


subject: GTOPDB:4942

object_name: B-cell chronic lymphocytic leukemia


subject: GTOPDB:4942

object_name: chronic leukemia


subject: GTOPDB:4942


subject: GTOPDB:4942

object_name: Myelodysplasia


subject: GTOPDB:4942

object_name: Adult Myelodysplastic Syndrome


subject: GTOPDB:4942

object_name: childhood myelodysplastic syndrome


subject: GTOPDB:4942

object_name: Myelodysplastic Syndrome, CTCAE


subject: GTOPDB:4942

object_name: non-Hodgkin lymphoma


subject: GTOPDB:4942

object_name: Hodgkin Disease


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: CHEBI:167309

subject_name: Methadone

object_name: Drug Interactions


subject: CHEBI:63629

subject_name: Tizanidine


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: Lung squamous cell carcinoma recurrent


subject: UNII:QEN1X95CIX

object_name: Stage IV Lung Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UNII:2B218X5QIY

object_name: mild neurocognitive disorder


subject: UNII:2B218X5QIY

object_name: mild cognitive impairment


subject: UNII:2B218X5QIY

object_name: Parkinson disease


subject: CHEBI:41774

subject_name: Tamoxifen


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: PUBCHEM.COMPOUND:146212008

object_name: High grade glioma


subject: PUBCHEM.COMPOUND:146212008

object_name: malignant glioma


subject: UMLS:C5557419

subject_name: ATM Kinase/DNA-PK Inhibitor XRD-0394


subject: UMLS:C5557419


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Adult Solid Neoplasm


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: vitreous detachment


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: metabolic disturbance


subject: CHEBI:71013

subject_name: Perampanel

object_name: SEIZURE DISORDER GENERALIZED TONIC CLONIC


subject: CHEBI:40799

subject_name: Boldione

object_name: prostate neoplasm


subject: CHEBI:64312

subject_name: Memantine

object_name: fragile X-associated tremor/ataxia syndrome


subject: CHEBI:42588

subject_name: Fenretinide

object_name: Neuroblastoma recurrent


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: Small bowel obstruction


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: familial pityriasis rubra pilaris


subject: UNII:089658A12D

object_name: pityriasis rubra pilaris


subject: CHEBI:4305

subject_name: dacarbazine

object_name: Advanced Melanoma


subject: UMLS:C1705207

subject_name: Endostar


subject: CHEBI:35221

subject_name: antimetabolite

object_name: graft versus host disease


subject: UMLS:C0003376

subject_name: Antimetabolites


subject: UMLS:C3536950

subject_name: Antimetabolite [EPC]


subject: UMLS:C4743406

object_name: Diabetic foot ulcer


subject: CHEBI:95117

object_name: Childhood Solid Neoplasm


subject: CHEBI:95117


subject: CHEBI:95117

object_name: Solid Neoplasm


subject: CHEBI:95117

object_name: Childhood Breast Carcinoma


subject: CHEBI:95117

object_name: breast carcinoma


subject: CHEBI:95117

object_name: breast cancer


subject: CHEBI:65324

subject_name: Alvespimycin


subject: CHEBI:65324

object_name: Adult Solid Neoplasm


subject: CHEBI:65324


subject: CHEBI:65324


subject: CHEBI:65324


subject: CHEBI:65324


subject: CHEBI:32184

subject_name: Tazarotene

object_name: neoplastic syndrome


subject: CHEBI:32184

object_name: neoplasm


subject: MESH:C000723557

object_name: Recurrent Primary Peritoneal Carcinoma


subject: MESH:C000723557

object_name: Recurrent Fallopian Tube Carcinoma


subject: MESH:C000723557

object_name: Recurrent ovarian cancer


subject: MESH:C000723557

object_name: undifferentiated ovarian carcinoma


subject: MESH:C000723557

object_name: ovarian clear cell cystadenocarcinoma


subject: MESH:C000723557

object_name: ovarian endometrioid adenocarcinoma


subject: MESH:C000723557

object_name: ovarian seromucinous carcinoma


subject: MESH:C000723557

object_name: ovarian serous cystadenocarcinoma


subject: UMLS:C5706391

subject_name: EGFR Mutant-selective Inhibitor BPI-361175

object_name: non-small cell lung carcinoma


subject: UMLS:C3642376

object_name: mantle cell lymphoma


subject: UMLS:C3642376

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C3642376

object_name: Indolent Non-Hodgkin Lymphoma


subject: UMLS:C3642376

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:4909

subject_name: Etodolac

object_name: outcomes general quality of life


subject: CHEBI:4909

object_name: Perceived quality of life


subject: CHEBI:4909

object_name: Good quality of life


subject: CHEBI:4909

object_name: Complete obstruction


subject: CHEBI:4909

object_name: Cardiovascular occlusion


subject: CHEBI:4909

object_name: Obstruction


subject: CHEBI:4909

object_name: Dental Occlusion


subject: CHEBI:4909

object_name: Occlusion


subject: CHEBI:91529


subject: CHEBI:91529


subject: CHEBI:91529


subject: CHEBI:91529


subject: CHEBI:91529


subject: CHEBI:91529


subject: CHEBI:91529


subject: CHEBI:91529


subject: PUBCHEM.COMPOUND:287691

subject_name: Thiocolchicoside


subject: PUBCHEM.COMPOUND:287691


subject: PUBCHEM.COMPOUND:287691


subject: PUBCHEM.COMPOUND:287691


subject: PUBCHEM.COMPOUND:287691


subject: PUBCHEM.COMPOUND:287691


subject: PUBCHEM.COMPOUND:287691


subject: PUBCHEM.COMPOUND:287691


subject: CHEBI:132922

object_name: acute kidney failure


subject: CHEBI:132922

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR

object_name: Mental deterioration


subject: CHEBI:3423

subject_name: Carmustine

object_name: metastatic melanoma


subject: UNII:4I67US2V8Q

object_name: alcohol abuse


subject: UNII:4I67US2V8Q

object_name: alcohol dependence


subject: CHEMBL.COMPOUND:CHEMBL3545406


subject: CHEMBL.COMPOUND:CHEMBL3545406


subject: UNII:LIA7Z4002P

subject_name: Nadroparin

object_name: lung cancer


subject: UNII:LIA7Z4002P

object_name: lung carcinoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: proteinuria


subject: UNII:4F4X42SYQ6

object_name: Proteinuria of undiagnosed cause


subject: UNII:4F4X42SYQ6

object_name: Proteinuria, CTCAE 3.0


subject: UNII:4F4X42SYQ6

object_name: Proteinuria, CTCAE 5.0


subject: UNII:4F4X42SYQ6

object_name: Focal Segmental Glomerulosclerosis, Not Otherwise Specified


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: pediatric angiosarcoma


subject: CHEBI:45863

object_name: angiosarcoma


subject: CHEBI:45863

object_name: Adult Angiosarcoma


subject: CHEBI:8774

subject_name: Ramipril

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:8774

object_name: metabolic syndrome X


subject: CHEBI:63918

subject_name: Artesunate

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:63918

object_name: Leukemia - chronic myeloid leukemia (CML)


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: acute lymphoblastic leukemia


subject: UMLS:C2983777


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: atopic eczema/dermatitis (non-specific)


subject: UMLS:C3658854


subject: CHEBI:6538

subject_name: Loratadine

object_name: lymphangioleiomyomatosis


subject: CHEBI:6538

object_name: lung lymphangioleiomyomatosis


subject: UMLS:C5556689

object_name: Childhood Solid Neoplasm


subject: UMLS:C5556689

object_name: Adult Solid Neoplasm


subject: UMLS:C5556689

object_name: Solid Neoplasm


subject: UMLS:C5556689

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5556689

object_name: Embolism, Tumor


subject: UMLS:C5556689

object_name: Neoplasm Metastasis


subject: UMLS:C5556689

object_name: Advanced cancer


subject: UMLS:C5556689

object_name: Gastroesophageal Junction Carcinoma


subject: UMLS:C5556689

object_name: esophageal adenocarcinoma


subject: UMLS:C5556689

object_name: Stomach cancer


subject: UMLS:C5556689

object_name: gastric cancer


subject: UNII:8MSM5N7RMK

subject_name: GIVASTOMIG


subject: UNII:8MSM5N7RMK


subject: UNII:8MSM5N7RMK


subject: UNII:8MSM5N7RMK


subject: UNII:8MSM5N7RMK


subject: UNII:8MSM5N7RMK


subject: UNII:8MSM5N7RMK


subject: UNII:8MSM5N7RMK


subject: UNII:8MSM5N7RMK


subject: UNII:8MSM5N7RMK


subject: UNII:8MSM5N7RMK


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C4721874

subject_name: human insulin

object_name: Diabetes


subject: UMLS:C4721874

object_name: diabetes mellitus


subject: UMLS:C0306371

subject_name: Humulin R


subject: CHEBI:6933

subject_name: Midodrine

object_name: stroke disorder


subject: CHEBI:6933

object_name: cerebrovascular disorder


subject: CHEBI:6933

object_name: Stroke (heart beat)


subject: CHEBI:6933

object_name: Stroke, CTCAE


subject: UNII:21970JMA97

subject_name: LUPARTUMAB AMADOTIN

object_name: neoplasm


subject: UMLS:C3896737


subject: MESH:C000718012

subject_name: sucrosomial iron

object_name: heart failure


subject: MESH:C000718012

object_name: Heart Failure, CTCAE


subject: MESH:C000718012

object_name: vitamin D deficiency


subject: MESH:C000718012

object_name: systolic heart failure


subject: MESH:C000718012

object_name: Heart failure NYHA class II


subject: MESH:C000718012

object_name: Heart failure NYHA class III


subject: UMLS:C5544915


subject: UMLS:C5544915


subject: UMLS:C5544915


subject: UMLS:C5544915


subject: UMLS:C5544915


subject: UMLS:C5544915


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:135702

subject_name: Belotecan

object_name: small cell carcinoma


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Erosive osteoarthrosis


subject: UNII:FYS6T7F842

object_name: Erosive (osteo)arthritis


subject: CHEBI:135552

subject_name: Prucalopride

object_name: psychosis


subject: UMLS:C3843379

subject_name: Patch estrogen

object_name: primary ovarian failure


subject: UMLS:C3843379

object_name: premature menopause


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: CHEBI:44915

subject_name: Propofol

object_name: Rotator Cuff Injuries


subject: CHEBI:44915

object_name: musculoskeletal system disorder


subject: CHEBI:44915

object_name: Rotator cuff tear


subject: CHEBI:44915

object_name: Sports Injury


subject: UNII:55VNK5440P

object_name: melanoma


subject: UMLS:C1328147

subject_name: Pivanex


subject: CHEMBL.COMPOUND:CHEMBL2108161

subject_name: TUBERCULIN

object_name: Genital warts


subject: UMLS:C0041289

subject_name: tuberculin


subject: CHEBI:50687

subject_name: metronidazole hydrochloride

object_name: Helicobacter pylori infection


subject: UMLS:C5238981

subject_name: Thymidylate Synthase Inhibitor CX1106

object_name: head and neck squamous cell carcinoma


subject: UNII:3NU609VYNF

object_name: Refractory acute myeloid leukemia


subject: UNII:3NU609VYNF

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C4079767


subject: UMLS:C4079767


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib

object_name: B-cell lymphoma recurrent


subject: UNII:WJA5UO9E10

object_name: B-cell lymphoma refractory


subject: CHEBI:42797

subject_name: Gabapentin

object_name: end stage renal failure


subject: CHEBI:42797

object_name: Chronic uremia


subject: CHEBI:8888

subject_name: Ropinirole


subject: CHEBI:8888


subject: UMLS:C0773222

subject_name: Glucose powder

object_name: hypoglycemia


subject: CHEBI:74120

subject_name: Gly-Met

object_name: psoriasis vulgaris


subject: CHEBI:19229


subject: UniProtKB:P16733

subject_name: GM_HCMVA Envelope glycoprotein M (sprot)


subject: CHEBI:176724

subject_name: Etiracetam

object_name: childhood absence epilepsy


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Extreme immaturity


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UMLS:C5667066

subject_name: Anti-LILRB4 Monoclonal Antibody NGM831


subject: UMLS:C5667066

object_name: pancreatic neoplasm


subject: UMLS:C5667066

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5667066

object_name: malignant pancreatic neoplasm


subject: UMLS:C5667066

object_name: bladder transitional cell carcinoma


subject: UMLS:C5667066

object_name: non-small cell lung carcinoma


subject: UMLS:C5667066

object_name: prostate carcinoma


subject: UMLS:C5667066

object_name: prostate cancer


subject: UMLS:C5667066

object_name: cervical adenocarcinoma


subject: UMLS:C5667066

object_name: endocervical carcinoma


subject: UMLS:C5667066

object_name: colorectal carcinoma


subject: UMLS:C5667066

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5667066

object_name: clear cell renal carcinoma


subject: UMLS:C5667066

object_name: renal cell adenocarcinoma


subject: UMLS:C5667066

object_name: renal cell carcinoma


subject: UMLS:C5667066

object_name: carcinoma of esophagus


subject: UMLS:C5667066

object_name: esophageal cancer


subject: UMLS:C5667066

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5667066

object_name: neoplasm of esophagus


subject: UMLS:C5667066

object_name: cholangiocarcinoma


subject: UMLS:C5667066

object_name: cervical cancer


subject: UMLS:C5667066

object_name: cervical carcinoma


subject: UMLS:C5667066

object_name: Stomach cancer


subject: UMLS:C5667066

object_name: gastric cancer


subject: UMLS:C5667066

object_name: ovarian cancer


subject: UMLS:C5667066

object_name: ovarian neoplasm


subject: UMLS:C5667066

object_name: ovarian carcinoma


subject: UMLS:C5667066

object_name: Childhood Breast Carcinoma


subject: UMLS:C5667066

object_name: breast carcinoma


subject: UMLS:C5667066

object_name: breast cancer


subject: UMLS:C5667066

object_name: Mesothelioma


subject: UMLS:C5667066

object_name: mesothelial neoplasm


subject: UMLS:C5667066

object_name: malignant mesothelioma


subject: UMLS:C5667066

object_name: melanoma


subject: UMLS:C5706375

subject_name: Anti-LAIR1 Monoclonal Antibody NGM438

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5706375

object_name: pancreatic neoplasm


subject: UMLS:C5706375

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5706375

object_name: malignant pancreatic neoplasm


subject: UMLS:C5706375

object_name: bladder transitional cell carcinoma


subject: UMLS:C5706375

object_name: non-small cell lung carcinoma


subject: UMLS:C5706375

object_name: prostate carcinoma


subject: UMLS:C5706375

object_name: prostate cancer


subject: UMLS:C5706375

object_name: cervical adenocarcinoma


subject: UMLS:C5706375

object_name: endocervical carcinoma


subject: UMLS:C5706375

object_name: colorectal carcinoma


subject: UMLS:C5706375

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5706375

object_name: clear cell renal carcinoma


subject: UMLS:C5706375

object_name: renal cell adenocarcinoma


subject: UMLS:C5706375

object_name: renal cell carcinoma


subject: UMLS:C5706375

object_name: carcinoma of esophagus


subject: UMLS:C5706375

object_name: esophageal cancer


subject: UMLS:C5706375

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5706375

object_name: neoplasm of esophagus


subject: UMLS:C5706375

object_name: cholangiocarcinoma


subject: UMLS:C5706375

object_name: cervical cancer


subject: UMLS:C5706375

object_name: cervical carcinoma


subject: UMLS:C5706375

object_name: Stomach cancer


subject: UMLS:C5706375

object_name: gastric cancer


subject: UMLS:C5706375

object_name: ovarian cancer


subject: UMLS:C5706375

object_name: ovarian neoplasm


subject: UMLS:C5706375

object_name: ovarian carcinoma


subject: UMLS:C5706375

object_name: Childhood Breast Carcinoma


subject: UMLS:C5706375

object_name: breast carcinoma


subject: UMLS:C5706375

object_name: breast cancer


subject: UMLS:C5706375

object_name: Mesothelioma


subject: UMLS:C5706375

object_name: mesothelial neoplasm


subject: UMLS:C5706375

object_name: malignant mesothelioma


subject: UMLS:C5706375

object_name: melanoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: endocervical carcinoma


subject: CHEBI:2682

subject_name: Amphotericin B

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:2682

object_name: acute myeloid leukemia


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: malaria


subject: MESH:C000632500

subject_name: reolysin

object_name: Carcinoma breast stage IV


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Hypertensive (finding)


subject: CHEBI:3654

subject_name: Chlorthalidone


subject: PUBCHEM.COMPOUND:91976568

subject_name: Teduglutide

object_name: Ileostomy - stoma


subject: UMLS:C1098514


subject: CHEBI:49668

subject_name: Gefitinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:49668

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:49668

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:49668

object_name: Stage IVA Basal Cell Lip Carcinoma


subject: CHEBI:49668

object_name: Stage IVB Basal Cell Lip Carcinoma


subject: CHEBI:49668

object_name: Stage IVC Basal Cell Lip Carcinoma


subject: CHEBI:49668

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:49668

object_name: Metastatic Parathyroid Gland Carcinoma


subject: CHEBI:49668

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:49668

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49668

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:49668

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49668

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49668

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:49668

object_name: untreated metastatic squamous neck cancer with occult primary


subject: CHEBI:49668

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:49668

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:49668

object_name: tongue cancer


subject: CHEBI:49668

object_name: tongue carcinoma


subject: CHEBI:49668

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49668

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:49668

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:49668

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49668

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49668

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:49668

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:49668

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:49668

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:49668

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:49668

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:49668

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:49668

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:49668

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:49668

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:49668

object_name: Laryngeal verrucous carcinoma stage III


subject: CHEBI:49668

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:49668

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:49668

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:49668

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:49668

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:49668

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:49668

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:49668

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:49668

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:49668

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:49668

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:49668

object_name: Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:49668

object_name: stage IVA adenoid cystic carcinoma of the oral cavity


subject: CHEBI:49668

object_name: stage IVB adenoid cystic carcinoma of the oral cavity


subject: CHEBI:49668

object_name: Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:49668

object_name: stage IVC adenoid cystic carcinoma of the oral cavity


subject: CHEBI:49668

object_name: Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:49668

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:49668

object_name: Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:49668

object_name: stage IVB mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:49668

object_name: Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:49668

object_name: stage IVC mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:49668

object_name: Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:49668

object_name: stage IVA mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:49668

object_name: medullary thyroid gland carcinoma


subject: CHEBI:49668

object_name: poorly differentiated thyroid gland carcinoma


subject: CHEBI:49668

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: stage IVC inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: stage IVB inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: stage IVB midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: stage IVC midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: stage IVA midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: stage IVB esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: stage IVA esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: stage IVC esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: stage IVA inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:49668

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:49668

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:49668

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:49668

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49668

object_name: stage IVB salivary gland cancer


subject: CHEBI:49668

object_name: stage IVC salivary gland cancer


subject: CHEBI:49668

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49668

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49668

object_name: stage IVA salivary gland cancer


subject: CHEBI:49668

object_name: Salivary gland cancer stage III


subject: CHEBI:49668

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49668

object_name: Recurrent Parathyroid Gland Carcinoma


subject: CHEBI:49668


subject: CHEBI:49668

object_name: stage IVA papillary thyroid cancer


subject: CHEBI:49668

object_name: stage IVB papillary thyroid cancer


subject: CHEBI:49668

object_name: stage IVC papillary thyroid cancer


subject: CHEBI:49668

object_name: stage III papillary thyroid cancer


subject: CHEBI:49668

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:49668

object_name: stage IVC follicular thyroid cancer


subject: CHEBI:49668

object_name: stage IVA follicular thyroid cancer


subject: CHEBI:49668

object_name: stage IVB follicular thyroid cancer


subject: CHEBI:49668

object_name: stage IVA lymphoepithelioma of the oropharynx


subject: CHEBI:49668

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:49668

object_name: stage IVC lymphoepithelioma of the oropharynx


subject: CHEBI:49668

object_name: stage IVB lymphoepithelioma of the oropharynx


subject: UMLS:C5958767

subject_name: c-Met-targeting Tri-specific Natural Killer Cell Engager ABBV-303

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297858

subject_name: BUDIGALIMAB


subject: UMLS:C4527193


subject: PUBCHEM.COMPOUND:73897520

object_name: Overweight


subject: PUBCHEM.COMPOUND:73897520

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:73897520

object_name: obesity


subject: PUBCHEM.COMPOUND:73897520

object_name: Obesity, CTCAE


subject: UNII:726I6TE06G

subject_name: PRAMLINTIDE ACETATE


subject: UNII:726I6TE06G


subject: UNII:726I6TE06G


subject: UNII:726I6TE06G


subject: UMLS:C1174779

subject_name: Symlin


subject: UMLS:C1174779


subject: UMLS:C1174779


subject: UMLS:C1174779


subject: PUBCHEM.COMPOUND:139600705

subject_name: Pramlintide


subject: CHEBI:174428

object_name: Depressed mood


subject: CHEBI:174428

object_name: Cancer patients and suicide and depression


subject: CHEBI:174428

object_name: Depressed - symptom


subject: CHEBI:174428

object_name: Depression, CTCAE


subject: CHEBI:174428

object_name: bipolar disorder


subject: CHEBI:174428

object_name: bipolar depression


subject: CHEBI:15414

subject_name: Adomet


subject: CHEBI:15414


subject: CHEBI:67040

subject_name: Ademetionine


subject: CHEBI:67040


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: acute leukemia


subject: CHEBI:90863

subject_name: Sonidegib


subject: UMLS:C0770255

subject_name: carbohydrate supplement


subject: UMLS:C0770255


subject: UMLS:C0770255


subject: UMLS:C1979799

subject_name: Psychiatric drugs

object_name: psychosis


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Bone fracture


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:75038

object_name: Coronary artery calcification


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: CHEBI:57397

subject_name: prostaglandin E1(1-)

object_name: congenital heart disease


subject: CHEBI:57397

object_name: Acquired pyloric stenosis


subject: CHEBI:15544

subject_name: Alprostadil


subject: UMLS:C0939797

subject_name: banana extract

object_name: cardiovascular disorder


subject: DRUGBANK:DB10505

subject_name: Banana


subject: CHEBI:78870

subject_name: sodium nitrite

object_name: Primary Graft Dysfunction


subject: CHEBI:94265

subject_name: Cerubidin

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:94265

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:64677

subject_name: Cerubidine

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:64677


subject: CHEBI:64677


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: UMLS:C4733650

subject_name: Prodrug APX001

object_name: candidiasis, invasive


subject: UMLS:C4733650

object_name: candidiasis


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Amputation, Traumatic


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Wounds and Injuries


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:3565

subject_name: Cetrimide


subject: CHEBI:232882

subject_name: CETRIMIDE


subject: CHEBI:39561

subject_name: Cetrimonium


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: pyelonephritis


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:5931

subject_name: insulin human

object_name: coronary atherosclerosis


subject: UMLS:C0876064

subject_name: Lantus

object_name: coronary artery disorder


subject: UMLS:C0876064


subject: CHEBI:91899

object_name: obstructive sleep apnea syndrome


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:2668

subject_name: Amlodipine

object_name: chronic kidney disease


subject: CHEBI:2668

object_name: Hypertensive nephrosclerosis


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904

object_name: Chronic uremia


subject: CHEBI:6904


subject: CHEBI:8774

subject_name: Ramipril


subject: UNII:A49A7A5YN4

subject_name: Alflutinib

object_name: non-small cell lung carcinoma


subject: CHEBI:50692

subject_name: Mifepristone

object_name: prostate carcinoma


subject: CHEBI:50692

object_name: prostate cancer


subject: CHEBI:50692

object_name: prostate adenocarcinoma


subject: UMLS:C2726835

subject_name: FentaNYL Matrix

object_name: chronic pain (diagnosis)


subject: UMLS:C2726835

object_name: Chronic pain


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: PUBCHEM.COMPOUND:5458171


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Complication of transplanted liver


subject: CHEBI:40237

subject_name: Sitagliptin


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C1948073


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: heparin-induced thrombocytopenia


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:151315

subject_name: Heparin


subject: UMLS:C2054270

subject_name: Tdap vaccine

object_name: pregnancy related


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered

object_name: wet macular degeneration


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Thromboembolism


subject: UNII:01F4FRP8YL

subject_name: mirogabalin

object_name: Diabetic peripheral neuropathic pain


subject: PUBCHEM.COMPOUND:66696998

subject_name: Mirogabalin


subject: CHEBI:135622

subject_name: Besifloxacin

object_name: corneal ulcer


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: CHEBI:5280

subject_name: Gatifloxacin


subject: CHEBI:3139

subject_name: bleomycin

object_name: keloid


subject: DRUGBANK:DB17809

subject_name: Puumala virus DNA vaccine

object_name: Hantavirosis


subject: DRUGBANK:DB17809

object_name: hantavirus hemorrhagic fever with renal syndrome


subject: CHEMBL.COMPOUND:CHEMBL3707359

subject_name: DAXIBOTULINUMTOXINA

object_name: Torticollis


subject: CHEBI:6916

subject_name: Mexiletine

object_name: sporadic amyotrophic lateral sclerosis


subject: CHEBI:8499

subject_name: Propranolol

object_name: nicotine dependence


subject: UMLS:C3827082

object_name: Refractory Lung Non-Small Cell Carcinoma


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893

object_name: Non-small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:51038893

object_name: Stage IV Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:11422859

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:180653

subject_name: Molnupiravir

object_name: severe acute respiratory syndrome


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Postoperative Pain, Acute


subject: GTOPDB:8221

subject_name: epacadostat

object_name: Stage III Primary Peritoneal Cancer AJCC v7


subject: GTOPDB:8221

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: GTOPDB:8221

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: GTOPDB:8221

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: GTOPDB:8221

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: GTOPDB:8221

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: GTOPDB:8221

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: GTOPDB:8221

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: GTOPDB:8221

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: GTOPDB:8221

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: GTOPDB:8221

object_name: Ovarian cancer stage III


subject: GTOPDB:8221

object_name: Stage IIIC Ovarian Cancer


subject: GTOPDB:8221

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: GTOPDB:8221

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: GTOPDB:8221

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UMLS:C1958331

object_name: malignant disease


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:63632

subject_name: Topotecan


subject: PUBCHEM.COMPOUND:66621102

object_name: Gaucher disease


subject: CHEBI:85089

subject_name: Ledipasvir


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:63918

subject_name: Artesunate

object_name: Enamel hypomineralization


subject: CHEBI:18231

subject_name: arsenic acid


subject: UniProtKB:P0AF61

subject_name: GHOS_ECOLI Endoribonuclease antitoxin GhoS (sprot)


subject: PR:000002156


subject: PR:000006315

subject_name: protein artemis


subject: PR:000003846

subject_name: agouti-related protein


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: microscopic polyangiitis


subject: CHEBI:5801

object_name: granulomatosis with polyangiitis


subject: CHEBI:5801

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: CHEBI:5801

object_name: eosinophilic granulomatosis with polyangiitis


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Control of hip fracture risk


subject: CHEBI:60789

object_name: hip fracture


subject: CHEBI:94366

subject_name: itraconazole

object_name: Childhood Solid Neoplasm


subject: CHEBI:94366

object_name: Adult Solid Neoplasm


subject: UNII:8375F9S90C

subject_name: Pamiparib


subject: UNII:8375F9S90C


subject: UNII:8375F9S90C

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: CHEBI:35498

subject_name: diuretic

object_name: Critical Illness


subject: CHEBI:35498

object_name: septic shock


subject: CHEBI:35498

object_name: heart disorder


subject: CHEBI:35498

object_name: Surgical procedure finding


subject: CHEBI:35498

object_name: Sepsis


subject: CHEBI:35498

object_name: Sepsis, CTCAE


subject: UMLS:C0012798

subject_name: Diuretics


subject: UMLS:C0012798


subject: UMLS:C0012798


subject: UMLS:C0012798


subject: UMLS:C0012798


subject: UMLS:C0012798


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Metastatic Kidney Carcinoma


subject: UNII:4Z63YK6E0E

object_name: nonpapillary renal cell carcinoma


subject: UNII:4Z63YK6E0E

object_name: clear cell renal carcinoma


subject: UNII:4Z63YK6E0E

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:4Z63YK6E0E

object_name: bladder transitional cell carcinoma


subject: UNII:4Z63YK6E0E

object_name: transitional cell carcinoma


subject: UNII:4Z63YK6E0E

object_name: malignant urinary system neoplasm


subject: CHEBI:8382

subject_name: Prednisone

object_name: atopic eczema


subject: CHEBI:50634

object_name: Altitude Hypoxia


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:39548

subject_name: Atorvastatin


subject: MESH:C459360

object_name: stroke disorder


subject: MESH:C459360

object_name: cerebrovascular disorder


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: breast neoplasm


subject: UNII:0VMV8Z3972

object_name: brain neoplasm


subject: UNII:0VMV8Z3972

object_name: medulloblastoma


subject: UNII:0VMV8Z3972

object_name: childhood medulloblastoma


subject: UNII:0VMV8Z3972

object_name: adult medulloblastoma


subject: UMLS:C5447430

subject_name: Fluorine F 18 DPA-714


subject: UMLS:C5447430


subject: UMLS:C5447430


subject: UMLS:C5447430


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: PSA Progression


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: ovarian serous tumor


subject: UNII:68AYS9A614

object_name: ovarian endometrial cancer


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: esophageal atresia


subject: CHEBI:4466

object_name: abscess; pleura


subject: CHEBI:4466

object_name: hidrocystoma


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:50848

subject_name: Loteprednol

object_name: Disorder of intraocular pressure


subject: CHEBI:50848

object_name: Intraocular Pressure


subject: CHEBI:50848

object_name: Corneal opacity


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: UMLS:C4722236

subject_name: Acacia senegal extract


subject: UMLS:C5241558

subject_name: Acacia arabica allergenic extract


subject: DRUGBANK:DB10451

subject_name: Acacia


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline

object_name: Childhood Breast Carcinoma


subject: CHEBI:9332

subject_name: Sulfamethoxazole

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:9332

object_name: obesity


subject: CHEBI:9332

object_name: Obesity, CTCAE


subject: CHEBI:9332

object_name: papillary craniopharyngioma


subject: CHEBI:9332

object_name: PCP - Hallucinogen-Related Disorder


subject: CHEBI:9332

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:45924


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Marijuana Usage


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: chronic obstructive pulmonary disease


subject: CHEBI:17561

subject_name: Cysteine


subject: UMLS:C3896794

object_name: ovarian cancer


subject: UMLS:C3896794

object_name: ovarian neoplasm


subject: UMLS:C3896794

object_name: ovarian carcinoma


subject: CHEBI:231342

subject_name: ceralasertib

object_name: childhood neoplasm


subject: CHEBI:231342

object_name: neoplastic syndrome


subject: CHEBI:231342

object_name: cancer or benign tumor


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C4305915

subject_name: Recombinant human relaxin

object_name: heart failure


subject: UMLS:C4305915

object_name: congestive heart failure


subject: UNII:W0122B976Y

subject_name: SERELAXIN


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: Macular Edema


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:38215

subject_name: calcium channel blocker

object_name: Preterm labor without delivery


subject: UMLS:C0006684

subject_name: Calcium Channel Blockers


subject: CHEBI:32599


subject: CHEBI:91775

subject_name: RITODRINE


subject: CHEBI:44915

subject_name: Propofol

object_name: Thoracic Diseases


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: Safety Issues


subject: UNII:4RA0KN46E0

object_name: inflammatory disease


subject: UNII:4RA0KN46E0

object_name: Adverse drug response


subject: UNII:4RA0KN46E0

object_name: Drug usage


subject: UNII:4RA0KN46E0

object_name: Drug use history


subject: UNII:4RA0KN46E0

object_name: Encounter due to drug use


subject: UNII:D07V79Q44T

object_name: cancer


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Advanced prostate cancer


subject: CHEBI:63584

subject_name: Cabazitaxel


subject: CHEMBL.COMPOUND:CHEMBL5095469

subject_name: RUGONERSEN

object_name: Angelman syndrome


subject: CHEBI:231350

subject_name: Pacritinib

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:52172

subject_name: Nilotinib

object_name: colon carcinoma


subject: CHEBI:52172

object_name: colorectal cancer


subject: CHEBI:52172

object_name: colon cancer


subject: CHEBI:2955

subject_name: Azithromycin

object_name: pulmonary sarcoidosis


subject: CHEBI:50777

subject_name: Etonogestrel

object_name: Abnormal uterine bleeding


subject: CHEBI:50777

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:50777

object_name: Dysmenorrhea


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: arthritis


subject: CHEBI:177512

subject_name: Sagopilone

object_name: neoplasm


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: laceration of skin (physical finding)


subject: CHEBI:4466

object_name: Skin laceration


subject: CHEBI:4466

object_name: Psychological Distress


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:17045

subject_name: Nitrous oxide


subject: CHEBI:17045


subject: CHEBI:17045


subject: GTOPDB:5026

subject_name: NGF

object_name: Abnormality of somatosensory evoked potentials


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: Metastatic transitional cell carcinoma


subject: CHEBI:91450

object_name: Locally Advanced Bladder Urothelial Carcinoma


subject: CHEBI:91450

object_name: Bladder transitional cell carcinoma stage IV


subject: CHEBI:91450

object_name: Bladder transitional cell carcinoma stage III


subject: CHEBI:567361

subject_name: Cladribine

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:567361

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:567361

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: CHEBI:567361

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:567361

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:567361

object_name: Refractory Acute Leukemia of Ambiguous Lineage


subject: CHEBI:567361

object_name: Refractory Acute Undifferentiated Leukemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026

object_name: Refractory Mixed Phenotype Acute Leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Refractory acute myeloid leukemia


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: UMLS:C4329323

object_name: head and neck cancer


subject: UMLS:C4329323

object_name: Childhood Solid Neoplasm


subject: UMLS:C4329323

object_name: Adult Solid Neoplasm


subject: UMLS:C4329323

object_name: Solid Neoplasm


subject: UMLS:C4329323

object_name: Childhood Breast Carcinoma


subject: UMLS:C4329323

object_name: breast carcinoma


subject: UMLS:C4329323

object_name: breast cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: cervical adenosquamous carcinoma


subject: PUBCHEM.COMPOUND:126961754

subject_name: Opioids

object_name: obstructive sleep apnea syndrome


subject: PUBCHEM.COMPOUND:126961754

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:126961754

object_name: obesity


subject: PUBCHEM.COMPOUND:126961754

object_name: Obesity, CTCAE


subject: CHEBI:35482

subject_name: opioid analgesic


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Prenatal diagnosis finding


subject: CHEBI:84040

object_name: colon carcinoma


subject: CHEBI:84040

object_name: colorectal cancer


subject: CHEBI:84040

object_name: colon cancer


subject: CHEBI:84040

object_name: cancer


subject: CHEBI:84040

object_name: neoplasm


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:27881


subject: UMLS:C2604746

object_name: Blood pressure ambulatory


subject: PUBCHEM.COMPOUND:129701655

subject_name: Cisplatin-fluorouracil

object_name: liver carcinoma


subject: CHEBI:9241

subject_name: Spironolactone

object_name: inherited disease susceptibility


subject: CHEBI:9241

object_name: Drug action (disorder)


subject: CHEBI:9637

subject_name: Torasemide


subject: CHEBI:9637


subject: CHEBI:74538

subject_name: Leu-Gly-Gly

object_name: dermatitis, atopic, 8


subject: UMLS:C0721277

subject_name: LGG brand of Dyphylline/Guaifenesin


subject: UMLS:C1832078

subject_name: LGG Lactobacillus rhamnosus GG


subject: CHEBI:84500

subject_name: varenicline

object_name: cervical cancer


subject: CHEBI:84500

object_name: cervical carcinoma


subject: CHEBI:84500

object_name: pancreatic neoplasm


subject: CHEBI:84500

object_name: exocrine pancreatic carcinoma


subject: CHEBI:84500

object_name: malignant pancreatic neoplasm


subject: CHEBI:84500

object_name: carcinoma of esophagus


subject: CHEBI:84500

object_name: esophageal cancer


subject: CHEBI:84500

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:84500

object_name: neoplasm of esophagus


subject: CHEBI:84500

object_name: Stomach cancer


subject: CHEBI:84500

object_name: gastric cancer


subject: CHEBI:84500

object_name: bladder tumor


subject: CHEBI:84500

object_name: urinary bladder carcinoma


subject: CHEBI:84500

object_name: urinary bladder cancer


subject: CHEBI:84500

object_name: childhood bladder carcinoma


subject: CHEBI:84500

object_name: renal carcinoma


subject: CHEBI:84500

object_name: kidney neoplasm


subject: CHEBI:84500

object_name: kidney cancer


subject: CHEBI:84500

object_name: liver cancer


subject: CHEBI:84500

object_name: liver neoplasm


subject: CHEBI:84500

object_name: Adult Liver Carcinoma


subject: CHEBI:84500

object_name: liver carcinoma


subject: CHEBI:84500

object_name: leukemia


subject: CHEBI:84500

object_name: childhood leukemia


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: pervasive developmental disorder


subject: CHEBI:36005

object_name: autism


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: UMLS:C3658787

object_name: Metastatic non-small cell lung cancer


subject: UNII:T9FVH03HMZ

subject_name: Calaspargase pegol

object_name: Infant T Acute Lymphoblastic Leukemia


subject: UNII:T9FVH03HMZ

object_name: T-cell childhood acute lymphocytic leukemia


subject: UNII:T9FVH03HMZ

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:50223

subject_name: Dexrazoxane

object_name: acute lymphoblastic leukemia


subject: CHEBI:50223


subject: CHEBI:50223

object_name: Pre T-ALL


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:50223

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:50223

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:50223

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:50223

object_name: acute biphenotypic leukemia


subject: CHEBI:50223

object_name: mixed phenotype acute leukemia


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911

object_name: acute leukemia of ambiguous lineage


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:45783


subject: CHEBI:45783


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: UNII:FTK8U1GZNX

subject_name: THIOGUANINE


subject: UNII:FTK8U1GZNX


subject: CHEBI:9555

subject_name: Tioguanine


subject: CHEBI:9555


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: UMLS:C1174783

subject_name: Zarnestra

object_name: Childhood Breast Carcinoma


subject: UMLS:C1174783

object_name: breast carcinoma


subject: UMLS:C1174783

object_name: breast cancer


subject: UMLS:C0393031


subject: UMLS:C0393031


subject: UMLS:C0393031


subject: UNII:WTT295HSY5

subject_name: Dulaglutide

object_name: Adolescent Obesity


subject: UNII:WTT295HSY5

object_name: Type 2 diabetes treated with insulin


subject: UMLS:C2976495


subject: UMLS:C2976495


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Myocardial Reperfusion Injury


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:24757

subject_name: Hypochlorite

object_name: Surgical Wound Infection


subject: CHEBI:44915

subject_name: Propofol

object_name: Cancer Other


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915

object_name: skin melanoma


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:6015

object_name: lung cancer


subject: CHEBI:6015

object_name: prostate carcinoma


subject: CHEBI:6015

object_name: prostate cancer


subject: CHEBI:6015


subject: CHEBI:6015


subject: CHEBI:6015

object_name: colorectal cancer


subject: CHEBI:6015

object_name: colorectal carcinoma


subject: CHEBI:6015

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:6015


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:4445

subject_name: Desflurane


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:50162

subject_name: motexafin gadolinium hydrate

object_name: pancreatic neoplasm


subject: CHEBI:50162

object_name: exocrine pancreatic carcinoma


subject: CHEBI:50162

object_name: malignant pancreatic neoplasm


subject: CHEBI:50162

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: CHEBI:50162

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: CHEBI:50162

object_name: gallbladder cancer


subject: CHEBI:50162

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: CHEBI:50162

object_name: Stage III Gallbladder Cancer AJCC v8


subject: CHEBI:50162

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: CHEBI:50162

object_name: gallbladder carcinoma


subject: CHEBI:50162

object_name: extrahepatic bile duct carcinoma


subject: CHEBI:50162

object_name: malignant tumor of extrahepatic bile duct


subject: PUBCHEM.COMPOUND:9919910

subject_name: Xcytrin


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEMBL.COMPOUND:CHEMBL3544910

subject_name: MOTEXAFIN GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: UNII:7N8K34P2XH

subject_name: Detomidine

object_name: Atypical behavior


subject: CHEBI:49166

subject_name: fluorodopa F 18

object_name: Cushing syndrome


subject: CHEBI:49166

object_name: adrenal gland hyperfunction


subject: CHEBI:49166

object_name: hyperaldosteronism


subject: CHEBI:49166

object_name: endocrine system disorder


subject: UNII:G083B71P98

subject_name: Pentetreotide


subject: UNII:G083B71P98


subject: UNII:G083B71P98


subject: UNII:G083B71P98


subject: CHEMBL.COMPOUND:CHEMBL2108757

subject_name: PENTETREOTIDE


subject: CHEMBL.COMPOUND:CHEMBL2108757


subject: CHEMBL.COMPOUND:CHEMBL2108757


subject: CHEMBL.COMPOUND:CHEMBL2108757


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Pain, Referred


subject: UMLS:C5205493

subject_name: Pucotenlimab

object_name: Stomach cancer


subject: UMLS:C5205493

object_name: gastric cancer


subject: UMLS:C1815380

subject_name: optivate

object_name: hereditary von Willebrand disease


subject: UMLS:C1815380

object_name: von Willebrand disease (hereditary or acquired)


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: lung disorder


subject: PUBCHEM.COMPOUND:156963654

object_name: Resectable non-small cell lung cancer


subject: PUBCHEM.COMPOUND:156963654

object_name: non-small cell lung carcinoma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: melanoma


subject: UMLS:C4526708


subject: DRUGBANK:DB17173


subject: CHEBI:6931

subject_name: Midazolam

object_name: Neck pain


subject: CHEBI:6931

object_name: Neck Pain, CTCAE 5.0


subject: CHEBI:6931

object_name: Neck Pain, CTCAE 3.0


subject: UMLS:C1611001

subject_name: ELB 139

object_name: panic disorder


subject: UMLS:C1611001

object_name: panic disorder 1


subject: CHEBI:47898

subject_name: Epirubicin

object_name: Barrett esophagus


subject: CHEBI:31348

subject_name: Capecitabine


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:4FR53SIF3A

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: MESH:D017780

subject_name: Malaria Vaccines

object_name: Plasmodium falciparum malaria


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:73604

object_name: periventricular nodular heterotopia


subject: CHEBI:73604

object_name: Hemolysis


subject: CHEBI:73604

object_name: Hemolysis - observation


subject: CHEBI:73604

object_name: Hemolysis, CTCAE


subject: CHEBI:4495

subject_name: Diazoxide

object_name: hypoglycemia


subject: CHEBI:4495

object_name: Blood glucose below reference range (finding)


subject: CHEBI:4495

object_name: Hypoglycemia, CTCAE


subject: CHEBI:4495

object_name: Infant, Large for Gestational Age


subject: CHEBI:4495

object_name: Pregnancy in Diabetics


subject: CHEBI:4495

object_name: Neonatal disorder


subject: UNII:18AP231HUP

subject_name: TEGAVIVINT

object_name: fibromatosis


subject: UNII:18AP231HUP

object_name: desmoid tumor


subject: UNII:18AP231HUP

object_name: Desmoid tumor


subject: DRUGBANK:DB17109

subject_name: Tegavivint


subject: DRUGBANK:DB17109


subject: DRUGBANK:DB17109


subject: CHEBI:6129

subject_name: Ketorolac

object_name: frozen shoulder


subject: CHEBI:6129

object_name: bursitis


subject: CHEBI:125427

object_name: autoimmune thrombocytopenia


subject: CHEBI:125427

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:125427

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:91414

subject_name: Adavosertib

object_name: Advanced Primary Peritoneal Carcinoma


subject: CHEBI:91414

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage III Primary Peritoneal Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:91414

object_name: Advanced Fallopian Tube Carcinoma


subject: CHEBI:91414

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:91414

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:91414

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:91414

object_name: Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:91414

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: Ovarian cancer stage III


subject: CHEBI:91414

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:91414

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: high grade ovarian serous adenocarcinoma


subject: CHEBI:91414

object_name: Carcinomatosis


subject: CHEBI:91414

object_name: carcinomatosis of unspecified behavior


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: congenital alveolar dysplasia


subject: CHEBI:16480

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:16480

object_name: newborn respiratory distress syndrome


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: Adult Acute Myeloid Leukemia in Remission


subject: DRUGBANK:DB17475

object_name: Previously Treated Myelodysplastic Syndrome


subject: DRUGBANK:DB17475

object_name: Leukemia, Myeloid, Chronic-Phase


subject: DRUGBANK:DB17475

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: DRUGBANK:DB17475

object_name: leukemia, myeloid, accelerated-phase


subject: DRUGBANK:DB17475

object_name: refractory anemia with excess blasts in transformation


subject: DRUGBANK:DB17475

object_name: myelodysplastic syndrome with excess blasts


subject: UMLS:C2827521

subject_name: Montanide ISA 51 VG


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: PUBCHEM.COMPOUND:11672494

subject_name: pr1 nanopeptide


subject: PUBCHEM.COMPOUND:11672494


subject: PUBCHEM.COMPOUND:11672494


subject: PUBCHEM.COMPOUND:11672494


subject: PUBCHEM.COMPOUND:11672494


subject: PUBCHEM.COMPOUND:11672494


subject: PUBCHEM.COMPOUND:11672494


subject: CHEMBL.COMPOUND:CHEMBL4297811

subject_name: PR1 LEUKEMIA PEPTIDE VACCINE


subject: CHEMBL.COMPOUND:CHEMBL4297811


subject: CHEMBL.COMPOUND:CHEMBL4297811


subject: CHEMBL.COMPOUND:CHEMBL4297811


subject: CHEMBL.COMPOUND:CHEMBL4297811


subject: CHEMBL.COMPOUND:CHEMBL4297811


subject: CHEMBL.COMPOUND:CHEMBL4297811


subject: UMLS:C0879440

subject_name: PR1 leukemia peptide vaccine


subject: UMLS:C0879440


subject: UMLS:C0879440


subject: UMLS:C0879440


subject: UMLS:C0879440


subject: UMLS:C0879440


subject: UMLS:C0879440


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: ANTICOAGULATION (finding)


subject: UMLS:C2825026

object_name: end stage renal failure


subject: UMLS:C2825026

object_name: Chronic uremia


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:151315


subject: CHEBI:151315


subject: CHEBI:94534

subject_name: olanzapine

object_name: Weight loss


subject: CHEBI:94534

object_name: Weight Loss, CTCAE


subject: UNII:AVK0I6HY2U

subject_name: Abaloparatide

object_name: postmenopausal osteoporosis


subject: UNII:AVK0I6HY2U

object_name: Vertebral osteoporosis


subject: UNII:AVK0I6HY2U

object_name: Osteoporotic Fractures


subject: UNII:AVK0I6HY2U

object_name: osteoporosis risk


subject: UNII:V038D626IF

subject_name: Ashwagandha

object_name: Muscle damage


subject: CHEBI:93786

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5555074

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5555074

object_name: acute myeloid leukemia


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Neurogenic bladder


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: Solid Neoplasm


subject: UMLS:C5854634

subject_name: Anti-PD-1/Anti-TGFbRII Bispecific Antibody INCA33890


subject: UMLS:C5959671

subject_name: KRAS G12D Inhibitor INCB161734


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: endometrial cancer


subject: UNII:DLE8519RWM

object_name: uterine corpus cancer


subject: UNII:DLE8519RWM

object_name: endometrial carcinoma


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: CHEBI:231601

subject_name: trastuzumab

object_name: female breast carcinoma


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:63638

subject_name: Vigabatrin

object_name: Tourette syndrome


subject: UNII:OJE5810C4F

subject_name: Taxoprexin

object_name: colorectal cancer


subject: UNII:OJE5810C4F

object_name: colorectal carcinoma


subject: UNII:OJE5810C4F

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:231683

subject_name: Anakinra

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:231683

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:231683

object_name: cell-associated neurotoxicity


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: coronary artery disorder


subject: UNII:R8DG7T2D3A

object_name: coronary atherosclerosis


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: neoplasm


subject: CHEBI:41774

object_name: digestive system neoplasm


subject: CHEBI:41774

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:7904

subject_name: Aredia

object_name: osteogenesis imperfecta


subject: UMLS:C0104018


subject: UMLS:C4085869

subject_name: Antibody-drug Conjugate SC-003

object_name: ovarian cancer


subject: UMLS:C4085869

object_name: ovarian neoplasm


subject: UMLS:C4085869

object_name: ovarian carcinoma


subject: UMLS:C4527193


subject: UMLS:C4527193


subject: UMLS:C4527193


subject: CHEMBL.COMPOUND:CHEMBL5095278

subject_name: LORIGERLIMAB

object_name: cervical cancer


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: cervical carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: Disseminated Malignant Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: Embolism, Tumor


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: Neoplasm Metastasis


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UNII:F2IBD1GMD3

subject_name: Paltusotine

object_name: acromegaly


subject: UNII:F2IBD1GMD3

object_name: Acral overgrowth


subject: MESH:C000627050

object_name: adult lymphoma


subject: MESH:C000627050

object_name: lymphoma


subject: MESH:C000627050

object_name: pediatric lymphoma


subject: MESH:C000627050

object_name: Advanced cancer


subject: UMLS:C3827098


subject: UMLS:C3827098


subject: UMLS:C3827098


subject: UMLS:C3827098


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:9824461

object_name: pain agnosia


subject: PUBCHEM.COMPOUND:9824461

object_name: Pain insensitivity


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: osteoarthritis, hip


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:174987

object_name: leukemia


subject: CHEBI:174987

object_name: childhood leukemia


subject: CHEBI:174987

object_name: Myelodysplasia


subject: CHEBI:174987


subject: CHEBI:16914

subject_name: Salicylic acid


subject: CHEBI:16914


subject: CHEBI:16914


subject: CHEBI:16914


subject: UMLS:C5853452

object_name: hemophilia A


subject: UNII:Z0O4TJ588O

subject_name: Posiphen

object_name: Alzheimer disease type 1


subject: MESH:C539751

subject_name: ankaferd blood stopper

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:71853

subject_name: Chitosan


subject: CHEBI:57704

subject_name: cationic chitosan


subject: CHEBI:16261

subject_name: chitosan


subject: UNII:T23U22X160


subject: UNII:T23U22X160


subject: UNII:T23U22X160


subject: CHEMBL.COMPOUND:CHEMBL4297816


subject: CHEMBL.COMPOUND:CHEMBL4297816


subject: CHEMBL.COMPOUND:CHEMBL4297816


subject: UMLS:C0935868

subject_name: paclitaxel liposome

object_name: Advanced gastric carcinoma


subject: UMLS:C5238363

subject_name: AGEN 1423

object_name: Advanced Pancreatic Ductal Adenocarcinoma


subject: UMLS:C5238363

object_name: pancreatic neoplasm


subject: UMLS:C5238363

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5238363

object_name: malignant pancreatic neoplasm


subject: UMLS:C5238363

object_name: pancreatic ductal adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: CHEBI:175901

subject_name: Gemcitabine


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C5556499

object_name: neoplasm


subject: CHEBI:3112

subject_name: Biperiden

object_name: cocaine abuse


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:95165

object_name: Neck Carcinoma


subject: CHEBI:95165

object_name: head and neck neoplasm


subject: CHEBI:95165

object_name: head and neck cancer


subject: CHEBI:95165

object_name: head and neck squamous cell carcinoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: MESH:C000716647

object_name: atopic eczema


subject: CHEBI:3219

subject_name: Bupropion

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:25657

subject_name: octyl group


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:5390

subject_name: Glu-Glu


subject: CHEBI:231594

subject_name: Norgestrel


subject: CHEBI:73529

subject_name: Leu-Asn


subject: CHEBI:17571


subject: CHEBI:33319

subject_name: lanthanoid atom


subject: PR:000010456

subject_name: melanophilin


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Advanced breast cancer


subject: CHEBI:38940

subject_name: Sunitinib

object_name: APUdoma


subject: CHEBI:38940

object_name: pancreatic neuroendocrine neoplasm


subject: UNII:26020H3Q1L

subject_name: Razupenem

object_name: cellulitis


subject: UNII:26020H3Q1L

object_name: skin infection


subject: UNII:807ME4B7IJ

subject_name: SELUMETINIB SULFATE

object_name: low grade glioma


subject: UNII:807ME4B7IJ

object_name: Metastatic Low Grade Glioma


subject: UNII:807ME4B7IJ

object_name: grade II glioma


subject: UNII:807ME4B7IJ

object_name: WHO Grade 1 Glioma


subject: UNII:807ME4B7IJ

object_name: Metastatic Low Grade Astrocytoma


subject: UNII:807ME4B7IJ

object_name: low-grade astrocytoma


subject: UNII:807ME4B7IJ

object_name: low grade astrocytic tumor


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: vulva cancer


subject: UMLS:C4727210

object_name: vulva carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: shigellosis


subject: UMLS:C0733521

subject_name: Ara-C

object_name: Langerhans cell histiocytosis


subject: UMLS:C0733521

object_name: Langerhans cell histiocytosis specific to childhood


subject: UMLS:C0733521

object_name: Langerhans cell histiocytosis specific to adulthood


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:85993

subject_name: Palbociclib

object_name: ductal breast carcinoma in situ


subject: UMLS:C3274613

subject_name: Copper Cu 64-DOTA-Anti-HER3 Monoclonal Antibody U3-1287

object_name: carcinoma


subject: UMLS:C3274613

object_name: adult lymphoma


subject: UMLS:C3274613

object_name: lymphoma


subject: UMLS:C3274613

object_name: pediatric lymphoma


subject: UMLS:C3274613

object_name: malignant soft tissue neoplasm


subject: UMLS:C3274613

object_name: sarcoma


subject: UMLS:C2698144


subject: UMLS:C2698144


subject: UMLS:C2698144


subject: UMLS:C2698144


subject: UMLS:C2698144


subject: UMLS:C2698144


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: head and neck neoplasm


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: UMLS:C2348637

subject_name: TLR9 Agonist SD-101

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C2348637

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C2348637

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C2348637

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C2348637

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C2348637

object_name: splenic marginal zone lymphoma


subject: CHEBI:173421

subject_name: Ethyl pyruvate

object_name: coronary artery disorder


subject: CHEBI:173421

object_name: heart valve disorder


subject: CHEBI:193615

object_name: carcinoma of esophagus


subject: CHEBI:193615

object_name: esophageal cancer


subject: CHEBI:193615

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:193615

object_name: neoplasm of esophagus


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: UMLS:C0962969

subject_name: RAD 001

object_name: uveal melanoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:72313

subject_name: pasireotide aspartate


subject: UMLS:C1136845


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide


subject: CHEMBL.COMPOUND:CHEMBL2108446

subject_name: GUAR GUM

object_name: gestational diabetes


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Haemodialysis-induced symptom


subject: CHEBI:35627

subject_name: beta-lactam

object_name: bacterial pneumonia


subject: UMLS:C1136571

object_name: Depressed mood


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)

object_name: ankylosing spondylitis


subject: PR:000010755


subject: UMLS:C0949110

subject_name: Aluminum hydroxide oral suspension BP

object_name: HIV infection


subject: UMLS:C5140447

subject_name: Sargramostim for Injection

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5853662


subject: CHEBI:9150

subject_name: Simvastatin

object_name: cancer


subject: CHEBI:9150

object_name: neoplasm


subject: CHEBI:9150

object_name: prostate carcinoma


subject: CHEBI:9150

object_name: prostate cancer


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: hormone receptor-positive breast cancer


subject: PUBCHEM.COMPOUND:284240

object_name: central nervous system cancer


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Heart failure with normal ejection fraction


subject: CHEBI:47426

subject_name: Furosemide


subject: UMLS:C1121680

subject_name: TMC 125

object_name: HIV-1 infection


subject: CHEBI:75958

subject_name: solution

object_name: Hypercholesterolemia


subject: UMLS:C0037633

subject_name: Solutions


subject: CHEBI:75998

subject_name: Trametinib

object_name: Non-small cell lung cancer stage III


subject: CHEBI:75998

object_name: Non-small cell lung cancer stage IIIA


subject: PUBCHEM.COMPOUND:118984463

subject_name: Insulin Tregopil

object_name: type 2 diabetes mellitus


subject: UNII:3UYC0OZ5ON

subject_name: INSULIN TREGOPIL


subject: UMLS:C4550894

subject_name: Insulin tregopil


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: osteogenesis imperfecta


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Recurrent Childhood Hepatocellular Carcinoma


subject: CHEBI:85994

object_name: Recurrent Adult Hepatocellular Carcinoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: GTOPDB:12989

object_name: Recurrent Hepatocellular Carcinoma


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:135515

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:135515

object_name: anaplastic large cell lymphoma


subject: CHEBI:74947

subject_name: Thalidomide

object_name: chronic pancreatitis


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: bladder tumor


subject: UNII:9AG41L3AOQ

object_name: urinary bladder carcinoma


subject: UNII:9AG41L3AOQ

object_name: urinary bladder cancer


subject: UNII:9AG41L3AOQ

object_name: childhood bladder carcinoma


subject: CHEBI:15940

subject_name: Niacin

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:15940

object_name: metabolic syndrome X


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:135942

subject_name: Laropiprant


subject: CHEBI:135942


subject: PUBCHEM.COMPOUND:10216733

subject_name: DIASTEREOMER 2


subject: PUBCHEM.COMPOUND:10216733


subject: UNII:2LHZ9ZC3YO

subject_name: Tolinapant

object_name: Solid Neoplasm


subject: UNII:2LHZ9ZC3YO

object_name: adult lymphoma


subject: UNII:2LHZ9ZC3YO

object_name: lymphoma


subject: UNII:2LHZ9ZC3YO

object_name: pediatric lymphoma


subject: CHEBI:5134

subject_name: Fluticasone

object_name: obstructive sleep apnea syndrome


subject: CHEBI:174615

object_name: granulomatous disease, chronic, X-linked


subject: CHEBI:28901

subject_name: Busulfan


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW

object_name: chronic granulomatous disease


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: UNII:QMS40680K6

subject_name: Palifermin


subject: UNII:QMS40680K6


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354


subject: CHEBI:9168

subject_name: Sirolimus


subject: UMLS:C3864947

subject_name: Gardasil 9

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C3864947

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: CHEBI:41879

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:9150

subject_name: Simvastatin

object_name: epilepsy


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR

object_name: neurodegenerative disease


subject: UMLS:C3899706

subject_name: Carbon C14-labeled Carboplatin

object_name: bladder tumor


subject: UMLS:C3899706

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: CHEBI:7025

subject_name: Mupirocin


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: GTOPDB:13676

subject_name: cosibelimab

object_name: Richter syndrome


subject: UNII:PNW7GBB44P

subject_name: COSIBELIMAB


subject: UMLS:C4726572


subject: UNII:U59UGK3IPC

subject_name: Ublituximab


subject: UMLS:C2934225


subject: RXCUI:498907

subject_name: amylase / lipase / protease Oral Capsule

object_name: exocrine pancreatic insufficiency


subject: UMLS:C0971122

subject_name: ICL 670A

object_name: beta thalassemia


subject: UMLS:C0971122

object_name: beta-thalassemia HBB/LCRB